期刊
EBIOMEDICINE
卷 20, 期 -, 页码 137-149出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ebiom.2017.05.028
关键词
Sodium glucose cotransporter-2 inhibitor; Obesity; Energy metabolism; Brown adipose tissue; Inflammation; Macrophage
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan [15K12698]
- Japan Diabetes Foundation
- [25282017]
- Grants-in-Aid for Scientific Research [15K12698, 16H03035, 17H06393] Funding Source: KAKEN
Sodium-glucose cotransporter (SGLT) 2 inhibitors increase urinary glucose excretion (UGE), leading to blood glucose reductions and weight loss. However, the impacts of SGLT2 inhibition on energy homeostasis and obesityinduced insulin resistance are less well known. Here, we show that empagliflozin, a SGLT2 inhibitor, enhanced energy expenditure and attenuated inflammation and insulin resistance in high-fat-diet-induced obese (DIO) mice. C57BL/6Jmicewere pair-fed a high-fat diet (HFD) or a HFDwith empagliflozin for 16weeks. Empagliflozin administration increased UGE in the DIO mice, whereas it suppressed HFD-induced weight gain, insulin resistance, and hepatic steatosis. Moreover, empagliflozin shifted energymetabolismtowards fat utilization, elevated AMP-activated protein kinase and acetyl-CoA carbolxylase phosphorylation in skeletalmuscle, and increased hepatic and plasma fibroblast growth factor 21 levels. Importantly, empagliflozin increased energy expenditure, heat production, and the expression of uncoupling protein 1 in brown fat and in inguinal and epididymal white adipose tissue (WAT). Furthermore, empagliflozin reduced M1-polarized macrophage accumulation while inducing the anti-inflammatory M2 phenotype of macrophages within WAT and liver, lowering plasma TNFa levels and attenuating obesity-related chronic inflammation. Thus, empagliflozin suppressed weight gain by enhancing fat utilization and browning and attenuated obesity-induced inflammation and insulin resistance by polarizing M2 macrophages inWAT and liver. (C) 2017 The Authors. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据